Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-07 Ling Geoffrey M.D. Director Grant or award +12,855 31,790
2021-10-01 Ling Geoffrey M.D. Director Grant or award +2,858 18,935
2021-07-01 Ling Geoffrey M.D. Director Grant or award +2,713 16,077
2021-06-09 Ling Geoffrey M.D. Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2021-04-01 Ling Geoffrey M.D. Director Grant or award +2,331 13,364
2021-01-05 Ling Geoffrey M.D. Director Grant or award +1,782 11,033
2020-10-01 Ling Geoffrey M.D. Director Grant or award +2,616 9,251
2020-07-01 Ling Geoffrey M.D. Director Grant or award +1,703 6,635
2020-06-11 Ling Geoffrey M.D. Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2020-04-01 Ling Geoffrey M.D. Director Grant or award +1,932 4,932
2020-02-25 Ling Geoffrey M.D. Director Purchase +3,000 $6.23 $19K 3,000
2020-01-15 Ling Geoffrey M.D. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000

Page 1 of 1 · 12 trades